FTC/TDF
State of the ART: HIV Management in 2025
Earlier initiation of ART and better medication options have resulted in a narrowing in the mortality gap between ...
JULY 3, 2025
Key Takeaways for PrEP, HIV Treatment and Other Infectious Diseases
CROI 2025 highlighted promising therapeutic modalities for HIV treatment and prevention.
JULY 3, 2025
Positive Results Announced in Lenacapavir and Bictegravir Trials
Late-breaking clinical data show promising results for products aimed at addressing unmet needs in HIV care, ...
FEBRUARY 25, 2025
FDA Expands Indication for Truvada for PrEP Among Adolescents
The FDA granted a new indication for Gilead's Truvada to reduce the risk for sexually acquired HIV-1 in at-risk ...
MAY 15, 2018
Load more